Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity
J Exp Med. 2024 Oct 7;221(10):e20231193. doi: 10.1084/jem.20231193. Epub 2024 Sep 25. ABSTRACT Upon antigenic stimulation, naïve CD4+ T cells can give rise to phenotypically
Biological foundation models illuminate annotation blind spots in evolutionarily divergent genomes
bioRxiv [Preprint]. 2026 May 16:2026.05.15.724572. doi: 10.64898/2026.05.15.724572. ABSTRACT Chromosome-scale assemblies are increasingly available for non-model organisms, but functional annotation remains limited when deep evolutionary divergence
Characterizing beta-lactam allergy prevalence among patients receiving infectious disease specialty care within a large US healthcare system in Washington
JAC Antimicrob Resist. 2026 Apr 7;8(2):dlag033. doi: 10.1093/jacamr/dlag033. eCollection 2026 Apr. ABSTRACT BACKGROUND: Unverified drug allergies pose a significant barrier to successful antimicrobial stewardship efforts.
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
bioRxiv. 2021 Aug 17:2021.08.17.456689. doi: 10.1101/2021.08.17.456689. Preprint. ABSTRACT The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously prevalent variants and
Safety, Outcomes, and Recommendations for Two-Step Outpatient Nonsteroidal Anti-Inflammatory Drug Challenges
J Allergy Clin Immunol Pract. 2022 May;10(5):1286-1292.e2. doi: 10.1016/j.jaip.2021.11.006. Epub 2021 Nov 17. ABSTRACT BACKGROUND: Nonsteroidal anti-inflammatory drug (NSAID) outpatient challenge protocols are not standardized.
A multiplexed, systems-based approach for prediction of antibody neutralization breadth for soluble human receptors
J Immunol. 2026 May 14;215(5):vkag106. doi: 10.1093/jimmun/vkag106. ABSTRACT For endemically circulating viruses, quantifying neutralization capacity of antibodies in a rapid and high-throughput manner is paramount